Which hedge funds own STTK? SHATTUCK LABS INC, Q2 2026 13F holders
Healthcare · Open on the interactive board
20 of the hedge funds tracked by WhaleCreep disclosed a position in STTK (SHATTUCK LABS INC) in their Q2 2026 13F filings, worth $289.9m in total. The largest holder by portfolio weight is NEXTBio Capital Management LP at 11.9% of its book. 8 managers opened a new position this quarter: West Tower Group, LLC, Frazier Life Sciences Management, L.P., Boxer Capital Management, LLC, Deep Track Capital, LP. 10 exited: Brevan Howard Capital Management LP, Catalyst Funds Management Pty LTD, Diadema Partners LP.
Who discovered STTK first?
Earliest meaningful positions among the 11 tracked managers we observed opening STTK since Q4 2020.
1 Avidity Partners Management LP First reported Q4 2020 1.7%initial weight · $49.2m Exitedby Q1 2022 · held 5q -84%stock since Q4 2020
Weight of Avidity Partners Management LP's 13F book in STTK, by quarter
- 1.7% peak weight, Q4 2020
- $56.2m peak reported value
- 5 quarters held
- 22q before the median tracked entry
The stock's split-adjusted price moved -84% between Q4 2020 and Q4 2021, the last quarter this manager reported the position.
23 managers already held STTK when our coverage of them began
NEXTBio Capital Management LP (Q1 2026), Prosight Management, LP (Q1 2026), Redmile Group, LLC (Q1 2026), Orbimed Advisors LLC (Q1 2026), 683 Capital Management, LLC (Q1 2026), Verdad Advisers, LP (Q1 2026), Sphera Funds Management Ltd. (Q1 2026), Adage Capital Partners GP, L.L.C. (Q1 2026), Hillsdale Investment Management Inc. (Q1 2026), Two Sigma Investments, LP (Q1 2026), Squarepoint Ops LLC (Q1 2026), Millennium Management LLC (Q1 2026), Brevan Howard Capital Management LP (Q1 2026), Catalyst Funds Management Pty LTD (Q1 2026), Citadel Advisors LLC (Q1 2026), Diadema Partners LP (Q1 2026), Diametric Capital, LP (Q1 2026), Engineers Gate Manager LP (Q1 2026), Hudson Bay Capital Management LP (Q1 2026), Marshall Wace, LLP (Q1 2026), Persistent Asset Partners LTD (Q1 2026), Qube Research & Technologies LTD (Q1 2026), Schonfeld Strategic Advisors LLC (Q1 2026).
Their first filing on record already includes STTK, so when they first bought it is unknown. They are not ranked above.
View discovery timeline
- Established ownershipQ4 2020 – now11 new tracked holders · 1.7% of tracked managers holding now
Dots mark the ranked managers' first reported quarters. Price is the quarter-end price implied by 13F filings, split-adjusted, shown from Q1 2026 where the series is continuous. Coverage widened in Q1 2026 from about a hundred managers to over a thousand, so holders and new holders are shown relative to the managers filing each quarter.
How this is calculated
13F filings are quarterly snapshots of long US-listed equity positions. They do not show exact purchase dates, intra-quarter trading, short positions, most derivatives, or a manager's actual performance. "First reported" is the first quarter-end filing that shows the position.
A manager is ranked only if we observed it filing, without STTK, within two quarters before its first position. Ranking is by the first quarter the position reached 1% of the manager's 13F book in a run of at least 2 filings, then by peak weight. "High conviction" means a peak weight of at least 5%.
Stock changes are the split-adjusted change in the quarter-end price implied by 13F filings, excluding dividends. They describe the stock over the period, not the return any manager earned. Phases are cut where the share of tracked managers holding STTK passed one third and two thirds of its peak.
Which hedge funds hold STTK? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| NEXTBio Capital Management LP | Q2 2026 | 11.9% | $25.9m | 3,727,348 | 18% | added |
| Prosight Management, LP | Q2 2026 | 7.1% | $41.3m | 5,957,877 | 19% | added |
| West Tower Group, LLC | Q2 2026 | 3.7% | $1.3m | 191,625 | – | new |
| Redmile Group, LLC | Q2 2026 | 3.2% | $47.8m | 6,892,033 | 24% | added |
| Orbimed Advisors LLC | Q2 2026 | 0.8% | $43.8m | 6,306,127 | 0% | held |
| 683 Capital Management, LLC | Q2 2026 | 0.7% | $8.0m | 1,157,216 | 45% | added |
| Frazier Life Sciences Management, L.P. | Q2 2026 | 0.6% | $26.0m | 3,750,000 | – | new |
| Boxer Capital Management, LLC | Q2 2026 | 0.5% | $6.9m | 1,000,000 | – | new |
| Verdad Advisers, LP | Q2 2026 | 0.4% | $397.2k | 57,231 | 328% | added |
| Deep Track Capital, LP | Q2 2026 | 0.4% | $25.7m | 3,706,734 | – | new |
| Sphera Funds Management Ltd. | Q2 2026 | 0.1% | $600.0k | 86,461 | -69% | reduced |
| Adage Capital Partners GP, L.L.C. | Q2 2026 | 0.1% | $56.4m | 8,122,179 | 75% | added |
| EntryPoint Capital, LLC | Q2 2026 | 0.0% | $183.1k | 26,387 | – | new |
| Hillsdale Investment Management Inc. | Q2 2026 | 0.0% | $1.8m | 263,418 | 303% | added |
| Gsa Capital Partners LLP | Q2 2026 | 0.0% | $474.0k | 68,371 | – | new |
| Fox Run Management, L.L.C. | Q2 2026 | 0.0% | $83.5k | 12,035 | – | new |
| Two Sigma Investments, LP | Q2 2026 | 0.0% | $1.3m | 185,947 | -41% | reduced |
| Squarepoint Ops LLC | Q2 2026 | 0.0% | $496.5k | 71,547 | 130% | added |
| Millennium Management LLC | Q2 2026 | 0.0% | $1.3m | 194,008 | -75% | reduced |
| Quarry LP | Q2 2026 | 0.0% | $180 | 26 | – | new |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Brevan Howard Capital Management LP | 0.0% | $511.0k |
| Catalyst Funds Management Pty LTD | 0.1% | $115.1k |
| Diadema Partners LP | 3.9% | $1.9m |
| Diametric Capital, LP | 0.1% | $118.5k |
| Engineers Gate Manager LP | 0.0% | $103.4k |
| Hudson Bay Capital Management LP | 0.1% | $1.5m |
| Marshall Wace, LLP | 0.1% | $3.7m |
| Persistent Asset Partners LTD | 0.5% | $477.3k |
| Qube Research & Technologies LTD | 0.0% | $815.3k |
| Schonfeld Strategic Advisors LLC | 0.0% | $74.2k |
Held in a manager's last filing on record
These managers have not filed for the latest quarter; their last disclosure is dated.
| Manager | Last filing | Weight |
|---|---|---|
| point72 | Q2 2026 | 0.0% |
| renaissance | Q2 2026 | 0.0% |
How has hedge fund ownership of STTK changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 22 | $303.2m |
| Q1 2026 | 25 | $193.8m |
| Q4 2025 | 2 | $5.1m |
| Q3 2025 | 1 | $518.3k |
| Q2 2025 | 1 | $30.2k |
| Q1 2025 | 1 | $26.6k |
| Q4 2024 | 1 | $34.0k |
| Q3 2024 | 1 | $874.6k |
| Q2 2024 | 1 | $1.5m |
| Q1 2024 | 2 | $1.9m |
| Q4 2023 | 2 | $6.2m |
| Q3 2023 | 1 | $303.0k |
| Q2 2023 | 1 | $711.0k |
| Q1 2023 | 1 | $730.0k |
| Q4 2022 | 1 | $589.0k |
| Q3 2022 | 1 | $716.0k |
Counts every tracked manager that disclosed STTK in that quarter's filing, including managers that have since stopped filing.